Josephine van Dongen

6 Non-specific effects of human rotavirus vaccination 155 prevalence of tuberculosis infection and a high prevalence of atopic disease. J Allergy Clin Immunol . 2003;111(3):541-549. doi:10.1067/mai.2003.171 17. Aaby P, Shaheen SO, Heyes CB, et al. Early BCG vaccination and reduction in atopy in Guinea-Bissau. ClinExpAllergy .2000;30(5):644-650.doi:10.1046/j.1365-2222.2000.00803.x 18. SteenhuisTJ,Van AalderenWMC, Bloksma N, et al. Bacille-Calmette-Guerin vaccination and the development of allergic disease in children: A randomized, prospective, single-blind study. Clin Exp Allergy . 2008;38(1):79-85. doi:10.1111/j.1365-2222.2007.02859.x 19. Hopkin JM, EnomotoT, Shimazu S, ShirakawaT. Inverse association between tuberculin responses and atopic disorder. Thorax . 1996;51(SUPPL. 3):1995-1998. doi:10.1136/thx.51. suppl_3.a1 20. Kandasamy R, Voysey M, McQuaid F, et al. Non-specific immunological effects of selected routine childhood immunisations: Systematic review. BMJ . 2016;355. doi:10.1136/bmj. i5225 21. Higgins JPT, Soares-Weiser K, López-López JA, et al. Association of BCG, DTP, and measles containing vaccines with childhood mor tality: Systematic review. BMJ . 2016;355. doi:10.1136/bmj.i5170 22. Clinicaltrials.gov. BCG and COVID trials. Published 2021. Accessed February 26, 2021. https://clinicaltrials.gov/ct2/results/map?cond=BCG+vaccine+AND+covid&map= 23. WHO Meeting of the Strategic Advisory Group of Exper ts on immunization, October 2017 – conclusions and recommendations. Wkly Epidemiol Rec . 2017;92(22):301-320. https:// www.who.int/wer/2017/wer9222/en/ 24. Rogers MAM, BasuT, Kim C. Lower Incidence Rate of Type 1 Diabetes after Receipt of the Rotavirus Vaccine in the United States, 2001–2017. Sci Rep . 2019;9(1):7727. doi:10.1038/ s41598-019-44193-4 25. World population by Country 2020. Accessed September 11, 2020. https:// worldpopulationreview.com/continents/capitals/europe 26. Reukers DFM,Asten L van, Brandsem PS, et al.Annual Repor t Surveillance of Influenza and Other Respiratory Infections in the Netherlands: Winter 2018/2019.; 2019. doi:DOI 10.21945/RIVM-2019-0079 27. Stensballe LG,Ravn H, Birk NM, et al.BCG vaccination at bir th and rate of hospitalization for infection until 15 months of age in Danish children: A randomized clinical multicenter trial. J Pediatric Infect Dis Soc . 2019;8(3):213-220. doi:10.1093/jpids/piy029 28. Wilson SE, Deeks SL, Rosella LC. Impor tance of ICD-10 coding directive change for acute gastroenteritis (unspecified) for rotavirus vaccine impact studies: Illustration from a population-based cohor t study from Ontario, Canada. BMC Res Notes . 2015;8(1):4-9. doi:10.1186/s13104-015-1412-5 29. Freyne B, Cur tis N. Does neonatal BCG vaccination prevent allergic disease in later life? Arch Dis Child . 2014;99(2):182-184. doi:10.1136/archdischild-2013-305655 30. Biering-Sørensen S, Jensen KJ, Monterio I, Ravn H, Aaby P, Benn CS. Rapid protective effects of early BCG on neonatal mor tality among low bir th weight boys: Observations from randomized trials. J Infect Dis . 2018;217(5):759-766. doi:10.1093/infdis/jix612 31. Biering-Sørensen S, Aaby P, Lund N, et al. Early BCG-Denmark and Neonatal Mor tality among Infants Weighing <2500 g: A Randomized Controlled Trial. Clin Infect Dis. 2017;65(7):1183-1190. doi:10.1093/cid/cix525 32. Steiner L, Diesner SC, Voitl P. Risk of infection in the first year of life in preterm children: An Austrian observational study. PLoS One . 2019;14(12):1-11. doi:10.1371/journal. pone.0224766